NuGen Medical Devices appoints R Buzbuzian as president, CEO and director

NuGen Medical Devices Inc. is pleased to announce that the Board of Directors has appointed Richard Buzbuzian as President, CEO and Director.

“InsuJet™, our needle-free injection device has tremendous sales opportunity globally and is approved for sale in 42 countries with active sales distribution agreements in 11. I look to complement our existing business with an expanded plan to monetize InsuJet sales with an ecommerce model, primarily B2C,” commented Richard Buzbuzian, NuGen’s President and CEO. “A particular region of initial interest for us is Europe where InsuJet is already approved for sale and a large TAM (total addressable market) is present, estimated to be upwards of 13B Euro for the diabetic market. Demand in this region could easily be met through an ecommerce model employing online purchasing with 3rd party shipping and fulfillment. A new method of deliver of care for diabetic patients using a historically proven ecommerce business model known for high volumes and high margins. I look forward to reporting more granularity on the roll out of this plan in the coming weeks ahead.”

The Company wishes to thank Derek Lindsay who has resigned as interim CEO and as a director effective today. Lindsay has agreed to assist the Company in its transition period as a consultant until April 14th, 2023.
MB Bureau